Trial Profile
Differential Intervention Trial by Standard Therapy Versus Pitavastatin in Patients With Chronic Hemodialysis.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Sep 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Cardiovascular disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- 24 Aug 2021 Status changed from active, no longer recruiting to discontinued.
- 22 Jun 2011 Planned end date changed from 1 Feb 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov.
- 26 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.